| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/21/2004 | CN1135388C Multilayer reagent test strip and method for making test with the same |
| 01/21/2004 | CN1135387C Volume-independent diagnostic test carrier and method for determining analyte with it |
| 01/21/2004 | CN1135386C Detection, measurement and control of thin webs of in-process textile materials |
| 01/21/2004 | CN1135235C Method for extracting prion protein and reagent kit |
| 01/21/2004 | CN1135114C Pigment mark poly-antibody and its preparing process |
| 01/21/2004 | CN1135113C Pigment marked polymerization antibody and preparation method thereof |
| 01/20/2004 | US6681186 Data processing, computers |
| 01/20/2004 | US6681127 Ocular analyte sensor |
| 01/20/2004 | US6681035 Method of unsupervised cell nuclei segmentation |
| 01/20/2004 | US6680743 Methods and apparatus for improved thermal printing |
| 01/20/2004 | US6680375 Antibody for use in the diagnosis, treatment and prevention of bone disorders and cancer |
| 01/20/2004 | US6680374 Invaplex is a composition of invasin protein(s) (i.e. a protein essential for the bacterium to enter a host cell) and a lipopolysaccharide; use as adjuvant for vaccines, and as diagnostic tool |
| 01/20/2004 | US6680373 Polypeptide for use in the human diagnostics and therapeutics |
| 01/20/2004 | US6680372 Antibodies specific for growth differentiation factor-7 |
| 01/20/2004 | US6680369 Nucleotide sequences coding protein for use in treatment cytoskeletal defects |
| 01/20/2004 | US6680368 Protein encoded by dna |
| 01/20/2004 | US6680367 Light emitting compounds; probes; receptor binding assays |
| 01/20/2004 | US6680366 Detecting antibodies; drug screening; genetic engineering |
| 01/20/2004 | US6680342 Monitoring the proliferation of cultured prostate cancer cells; obtain cells, incubate with quercetin, monitor adjustment in gene expression, decrease in androgen receptor gene expression indicate cell proliferation inhibitor |
| 01/20/2004 | US6680302 Administering a 6- mercaptopurine drug to a patient having immune-mediated gastrointestinal disorder and determining a level of 6-thioguanine in the patient |
| 01/20/2004 | US6680298 Administering polypeptide to increase serum levels; dietetics, hypoglycemic agents; cardiovascular, autoimmune, kidney, metabolic and nervous system disorder treatment |
| 01/20/2004 | US6680211 Fluorescent nanocrystal-embedded microspheres for fluorescence analysis |
| 01/20/2004 | US6680210 Matrix for monitoring preferential particles in sample |
| 01/20/2004 | US6680209 Analyzing samples containing human anti-mouse antibodies (hama) or heterophilic antibodies |
| 01/20/2004 | US6680208 Rapid protein identification using antibody mixtures |
| 01/20/2004 | US6680207 Detection of molecules in samples |
| 01/20/2004 | US6680204 Polymer for binding amine containing ligands and uses thereof |
| 01/20/2004 | US6680203 Fourier transform mass spectrometry of complex biological samples |
| 01/20/2004 | US6680201 Compound for use in clearing particulate matter from sample |
| 01/20/2004 | US6680193 Internal duct passing through support to form a connection between input and output bowls; genetic replication and polymerase chain reactions |
| 01/20/2004 | US6680191 Isolated nucleic acid molecules coding for tumor rejection antigen precursors of members of the MAGE-C and MAGE-B FAMILIES and uses thereof |
| 01/20/2004 | US6680188 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/20/2004 | US6680177 Coagulation cascade reaction and monitoring coagulation times or kinetics, wherein the coagulation reagent is a dry format reagent comprising magnetic particles and a factor xa activator |
| 01/20/2004 | US6680175 Diagnosing cancer in humans; obtain biopsy of human tissue, detect and measure signal from bound polypeptide marker, evaluate humans for cancer |
| 01/20/2004 | US6680174 Assay for growth differentiation factor 9 |
| 01/20/2004 | US6680173 Diagnosis of tauopathies |
| 01/20/2004 | US6680172 Diagnosing high grade glioma by detection of tax-1 protein or polypeptide; gene expression |
| 01/20/2004 | US6680054 Macromolecular neuraminidase-binding compounds |
| 01/20/2004 | US6679626 Method for determining the thermal materials properties of shaped metal parts |
| 01/20/2004 | US6679226 Fuel sensor system |
| 01/20/2004 | US6679105 Oscillatory erosion and transport flume with superimposed unidirectional flow |
| 01/20/2004 | US6679103 Continuous flow moisture analyzer for determining moisture content in liquid sample material |
| 01/20/2004 | US6679099 Gas sensor |
| 01/20/2004 | US6679098 High flow rate sample flow path assembly for electronic gas leak detectors |
| 01/20/2004 | US6679097 Method and apparatus for monitoring oxygen concentration in beverage production process |
| 01/20/2004 | US6679096 Method for the measurement of the concentration or the partial pressure of gases in fluids in gas sensor |
| 01/20/2004 | US6679095 Multi-test gravelometer |
| 01/20/2004 | US6679094 Calibration adapter for gas detection instrument |
| 01/20/2004 | US6679070 Method for identifying thawed and refrozen products |
| 01/20/2004 | CA2295001C Instrument performance verification system |
| 01/20/2004 | CA2264714C Method of sorting birds in ovo |
| 01/20/2004 | CA2264343C Method and apparatus for data management authentication in a clinical analyzer |
| 01/20/2004 | CA2115414C Technique for extracorporeal treatment of blood |
| 01/20/2004 | CA2101534C Monoclonal antibodies to putative hcv envelope region and methods for using same |
| 01/20/2004 | CA2090961C Specific binding agents |
| 01/20/2004 | CA2078427C Improved device and method of separating and assaying whole blood |
| 01/20/2004 | CA2076748C Flow immunosensor method and apparatus |
| 01/18/2004 | CA2432925A1 Enzymatic assay of hiv protease inhibitors |
| 01/16/2004 | CA2432940A1 Method for producing a microarray |
| 01/16/2004 | CA2393726A1 Quantitative proteomics via isotopically differentiated derivatization |
| 01/15/2004 | WO2004005935A1 Method of examining and diagnosing integration dysfunction syndrome |
| 01/15/2004 | WO2004005934A2 Toxicity markers |
| 01/15/2004 | WO2004005933A1 Reagents and a method for saturation labelling of proteins |
| 01/15/2004 | WO2004005932A2 Serological diagnostic method |
| 01/15/2004 | WO2004005931A1 Secreted polypeptide species associated with cardiovascular disorders |
| 01/15/2004 | WO2004005930A2 Diagnostic use of pharmaceutical substances and method for the diagnosis of human and animal neurodegenerative diseases |
| 01/15/2004 | WO2004005929A2 Methods and formulations for diagnosing, monitoring, staging and treating heart failure |
| 01/15/2004 | WO2004005928A2 Agents and methods for diagnosis and therapy of cancer and cancer risk assessment |
| 01/15/2004 | WO2004005927A1 Method for discrimination of metaplasias from neoplastic or preneoplastic lesions |
| 01/15/2004 | WO2004005926A2 5t4 antigen expression as a marker for stem cell differentiation |
| 01/15/2004 | WO2004005925A2 Diagnostics method |
| 01/15/2004 | WO2004005924A1 3d microarray |
| 01/15/2004 | WO2004005923A1 RABS AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 01/15/2004 | WO2004005922A2 Monitoring of cells |
| 01/15/2004 | WO2004005921A1 Diagnostic and therapeutic use of tb2 gene and protein for neurodegenerative diseases |
| 01/15/2004 | WO2004005920A2 Method for enriching and tracking pathologic modified prions-proteins (prpsc) |
| 01/15/2004 | WO2004005919A1 Device for quantitative analysis of biological materials |
| 01/15/2004 | WO2004005918A2 Characterization of biochips containing self-assembled monolayers with maldi-tof-ms |
| 01/15/2004 | WO2004005911A1 A method of assaying the antioxidant activity of pure compounds, extracts and biological fluids |
| 01/15/2004 | WO2004005908A1 Biosensor, biosensor chip, and biosensor device |
| 01/15/2004 | WO2004005907A1 Improved method of chemical sensing |
| 01/15/2004 | WO2004005903A1 A method for monitoring the properties of pharmaceutical articles |
| 01/15/2004 | WO2004005901A1 Detection of molecular identification by electrochemiluminescence on conductive polymer |
| 01/15/2004 | WO2004005899A1 Method and device for detecting protein association by dispersion constant variation |
| 01/15/2004 | WO2004005893A2 Apparatus for metering analytes contained in a liquid sample and related process |
| 01/15/2004 | WO2004005891A2 Expression profile of lung cancer |
| 01/15/2004 | WO2004005890A2 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof |
| 01/15/2004 | WO2004005888A2 Method for metal analysis and speciation and biosensor for effecting the method |
| 01/15/2004 | WO2004005887A2 Methods and compositions for the detection of pregnancy in ruminants |
| 01/15/2004 | WO2004005884A2 Method and apparatus for molecular mechanics analysis of molecular systems |
| 01/15/2004 | WO2004005883A2 Secreted and cytoplasmic tumor endothelial markers |
| 01/15/2004 | WO2004005882A2 Multi-parameter high throughput screening assays (mphts) |
| 01/15/2004 | WO2004005881A2 Methods for identification of compounds modulating insulin resistance |
| 01/15/2004 | WO2004005880A2 Analyzing method for activity of thyroid autoantibody |
| 01/15/2004 | WO2004005841A1 Gauge calibration |
| 01/15/2004 | WO2004005550A2 Method of screening for antidiabetic agents |
| 01/15/2004 | WO2004005544A2 Marker genes for determining renal toxicity |
| 01/15/2004 | WO2004005540A2 Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases |
| 01/15/2004 | WO2004005538A1 Method of screening anticancer agent |
| 01/15/2004 | WO2004005536A1 Nephrotoxicity marker fumarylacetoacetase |